Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine.

about

Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine.

P2860

Q38703120-EC6E41DA-7463-4E77-B875-515271E277A3 Q53758719-A2385F4D-DE4C-4D6A-8CE3-2EEC8121A0A6

P2860

Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine.

Item

http://www.wikidata.org/entity/Q52893159

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@en

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@nl

type

Item

label

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@en

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@nl

prefLabel

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@en

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@nl

P1476

Cytomegalovirus reactivation i ...... nts treated with bendamustine.

@en

P2093

Aya Watanabe

http://www.w3.org/2001/XMLSchema#string

Chihiro Asano

http://www.w3.org/2001/XMLSchema#string

Hanae Shimura

http://www.w3.org/2001/XMLSchema#string

Hideto Tamura

http://www.w3.org/2001/XMLSchema#string

Hiroki Sugimori

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kazama

http://www.w3.org/2001/XMLSchema#string

Junji Tanaka

http://www.w3.org/2001/XMLSchema#string

Koiti Inokuchi

http://www.w3.org/2001/XMLSchema#string

Michihiko Masuda

http://www.w3.org/2001/XMLSchema#string

Noriko Isono

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of virus infection by human CD4+ T cells via a cytokine relay network

Regulation of interferon-gamma during innate and adaptive immune responses

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.

Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.

Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.

Quantification of cytomegalovirus viral load.

Impact of interferon-γ on hematopoiesis.

Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma.

P304

2204-2207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1126589

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoichi Imai

Keiichi Moriya

Kenjiro Mitsuhashi

P577

2015-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26699798

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine.

about

P2860

P2860

Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921